letrozole has been researched along with Angiogenesis, Pathologic in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melasma is an acquired disorder of pigmentation that presents with asymptomatic symmetric darkening of the face." | 1.46 | Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor. ( Cohen, PR, 2017) |
| "Letrozole was effective for ovarian cancers with abundant expression of ERα." | 1.40 | Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice. ( Hirakawa, H; Mizunuma, H; Yokoyama, Y; Yoshida, H, 2014) |
| "Treatment of breast cancer cells following a preoperative protocol showed a dose-dependent expression of VEGF and Angiopoetin-1." | 1.32 | Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer. ( Armeanu, S; Fersis, N; Friedrich, M; Gagulic, E; Pantic, L; Relakis, K; Smyczek-Gargya, B; Wallwiener, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, PR | 1 |
| Hirakawa, H | 1 |
| Yokoyama, Y | 1 |
| Yoshida, H | 1 |
| Mizunuma, H | 1 |
| Jia, X | 1 |
| Hong, Q | 1 |
| Lei, L | 1 |
| Li, D | 1 |
| Li, J | 1 |
| Mo, M | 1 |
| Wang, Y | 1 |
| Shao, Z | 1 |
| Shen, Z | 1 |
| Cheng, J | 1 |
| Liu, G | 1 |
| Isanejad, A | 1 |
| Alizadeh, AM | 1 |
| Amani Shalamzari, S | 1 |
| Khodayari, H | 1 |
| Khodayari, S | 1 |
| Khori, V | 1 |
| Khojastehnjad, N | 1 |
| Banerjee, S | 1 |
| A'Hern, R | 1 |
| Detre, S | 1 |
| Littlewood-Evans, AJ | 1 |
| Evans, DB | 1 |
| Dowsett, M | 1 |
| Martin, LA | 1 |
| Fersis, N | 1 |
| Smyczek-Gargya, B | 1 |
| Armeanu, S | 1 |
| Gagulic, E | 1 |
| Pantic, L | 1 |
| Relakis, K | 1 |
| Friedrich, M | 1 |
| Wallwiener, D | 1 |
6 other studies available for letrozole and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
Topics: Administration, Topical; Anastrozole; Androstadienes; Aromatase Inhibitors; Estrogens; Female; Genet | 2017 |
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Aromatase I | 2014 |
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Diphosph | 2015 |
MicroRNA-206, let-7a and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined Modality Thera | 2016 |
Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Aromatase; Aromatase Inhibitors; | 2010 |
Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer.
Topics: Androstadienes; Angiopoietin-1; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; DNA Prime | 2004 |